Petition · past parliament
Reconsider making antiGD2 immunotherapy available as treatment for Neuroblastoma
Rejected
21 signatures
What the petition asks
Anti GD2 antibody treatment is proven to increase long term survival in children fighting neuroblastoma. It is par for the course in the US and Europe but has not been selected for NHS funding.
Why it was rejected
There was already a petition about this issue. Duplicates are rejected so signatures collect in one place.
Timeline
| 4 May 2018 | Petition opened for signatures |
| 10 May 2018 | Rejected by the Petitions Committee |
Key facts
Signatures
21
Status
Rejected
Rejected
10 May 2018
Follow this petition
Sign in to get an email when the government responds, a debate is scheduled or held, or the petition closes.
Source: the official petition page. Last checked 15 Jul 2026.